Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-15,700
Closed -$615K 2213
2019
Q4
$615K Buy
+15,700
New +$577K ﹤0.01% 1328
2018
Q4
Sell
-43,000
Closed -$1.97M 2773
2018
Q3
$1.97M Buy
43,000
+14,000
+48% +$705K 0.01% 728
2018
Q2
$1.53M Buy
29,000
+5,500
+23% +$292K 0.01% 1079
2018
Q1
$1.17M Buy
23,500
+10,300
+78% +$519K 0.01% 1171
2017
Q4
$633K Buy
+13,200
New +$625K 0.02% 588

Other funds holding SNV

Two Sigma Securities's SNV Position: Q1 2026 in Review

Two Sigma Securities sold out of Synovus (SNV) in Q1 2026, closing a stake of 10,770 shares — an estimated $539K sold.

Two Sigma Securities first reported a position in SNV in Q1 2017 and held it in 4 quarters. The position peaked at $539K in Q4 2025. 1 fund tracked by Wall St. Rank holds SNV as of Q1 2026.

  • Two Sigma Securities reported no remaining Synovus position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 10,770 Synovus shares in Q1 2026, an estimated $539K.
  • Two Sigma Securities first reported a position in Synovus in Q1 2017 and held it in 4 quarters.
  • Two Sigma Securities's Synovus position peaked at $539K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Synovus as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.